Allostery Investments LP Evolus, Inc. Transaction History
Allostery Investments LP
- $7.85 Billion
- Q2 2025
A detailed history of Allostery Investments LP transactions in Evolus, Inc. stock. As of the latest transaction made, Allostery Investments LP holds 60,000 shares of EOLS stock, worth $384,000. This represents 7.04% of its overall portfolio holdings.
Number of Shares
60,000
Previous 412,754
85.46%
Holding current value
$384,000
Previous $4.97 Billion
88.87%
% of portfolio
7.04%
Previous 7.16%
Shares
3 transactions
Others Institutions Holding EOLS
# of Institutions
186Shares Held
55.6MCall Options Held
1.21MPut Options Held
48.5K-
Tang Capital Management LLC San Diego, CA5MShares$32 Million2.76% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.2MShares$26.9 Million1.69% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$25.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.32MShares$21.2 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.47MShares$15.8 Million1.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $359M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...